The antibodies against 5-bromo-2′-deoxyuridine specifically recognize trifluridine incorporated into DNA
Trifluridine (FTD) is a key component of the novel oral antitumor drug TAS-102 (also named TFTD), which consists of FTD and a thymidine phosphorylase inhibitor. FTD is supposed to exert its cytotoxicity via massive misincorporation into DNA, but the underlying mechanism of FTD incorporation into DNA...
Main Authors: | Kitao, Hiroyuki, Morodomi, Yosuke, Niimi, Shinichiro, Kiniwa, Mamoru, Shigeno, Kazuhiko, Matsuoka, Kazuaki, Kataoka, Yuki, Iimori, Makoto, Tokunaga, Eriko, Saeki, Hiroshi, Oki, Eiji, Maehara, Yoshihiko |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853717/ |
Similar Items
-
Rad9, Rad17, TopBP1 and Claspin Play Essential Roles in Heat-Induced Activation of ATR Kinase and Heat Tolerance
by: Tuul, Munkhbold, et al.
Published: (2013) -
Phosphorylation of EB2 by Aurora B and CDK1 ensures mitotic progression and genome stability
by: Iimori, Makoto, et al.
Published: (2016) -
Molecular mechanisms regulating the hormone sensitivity of breast cancer
by: Tokunaga, Eriko, et al.
Published: (2014) -
Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women
by: Tokunaga, Eriko, et al.
Published: (2016) -
Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts
by: Suzuki, Norihiko, et al.
Published: (2016)